Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Jul;85(13):4672-6.
doi: 10.1073/pnas.85.13.4672.

Transcriptional activation of HLA-DR alpha by interferon gamma requires a trans-acting protein

M A Blanar  1 , E C Boettger, R A Flavell
Affiliations

Transcriptional activation of HLA-DR alpha by interferon gamma requires a trans-acting protein

M A Blanar et al. Proc Natl Acad Sci U S A. 1988 Jul.

Abstract

Stimulation of the human epithelial-like cell line, HeLa, with interferon gamma (IFN-gamma) induces steady-state levels of HLA-DR alpha mRNA. Using a sensitive RNase-mapping procedure, we detect induced HLA-DR alpha mRNA as early as 8 hr after IFN-gamma treatment; maximal accumulation occurs by 48 hr. Treatment with the protein synthesis inhibitor, cycloheximide, abolishes the IFN-gamma-induced accumulation of HLA-DR alpha mRNA, indicating that de novo synthesis of a trans-acting protein factor is required for induction of this major histocompatibility complex class II gene. Nuclear run-off transcription assays revealed that IFN-gamma acts by directly stimulating the transcription rate of HLA-DR alpha. Similarly, IFN-gamma increased the transcription rate of the class I HLA-A2-encoding gene as well as that of the human invariant chain gene. IFN-gamma-induced transcription of HLA-DR alpha and of the invariant chain gene was blocked by treatment with cycloheximide, but IFN-gamma-induced transcription of HLA-A2 was unaffected. Our findings show that transcriptional induction of HLA-DR alpha and the invariant chain gene by IFN-gamma requires the action of an unidentified trans-acting protein.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Virology. 1985 Jul 15;144(1):173-80 - PubMed
    1. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5145-9 - PubMed
    1. J Immunol. 1985 Dec;135(6):4235-8 - PubMed
    1. Nature. 1985 Nov 21-27;318(6043):291-3 - PubMed
    1. J Immunol. 1986 Jan;136(2):364-7 - PubMed

Publication types

MeSH terms